Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Cellular and Molecular Life Sciences : CMLS
|
July 12, 2026
Matrix stiffness induced CREB3L1 activation contributed to skin fibrosis through calcium influx triggered endoplasmic reticulum stress
Dongsheng Wen, Yeke Yu, Siyi He, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2022
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
ZhiCheng Lai, MinKe He, XiaoYun Bu, et al.
Angewandte Chemie (International Ed. in English)
|
March 12, 2024
Control of Polarity in Kagome-NiAs Bismuthides
Quinn D Gibson, Dongsheng Wen, Hai Lin, et al.
Medcomm
|
June 10, 2026
Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial
Zhicheng Lai, Aojie Ge, Hanyue Ouyang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 14, 2025
Type 2 Diabetes-Associated Phenylacetylglutamine Induces Deleterious Inflammation Cycle in Myeloid Cells through β<sub>2</sub> Adrenergic Receptors and Impedes Wound Healing
Lu Huang, Xinran Ye, Chia-Kang Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC)
MinKe He, YeXing Huang, ZeFeng Du, et al.
Technology in Cancer Research & Treatment
|
December 19, 2022
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials
YeXing Huang, LiHong Zhang, MinKe He, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Cellular and Molecular Life Sciences : CMLS
|
July 12, 2026
Matrix stiffness induced CREB3L1 activation contributed to skin fibrosis through calcium influx triggered endoplasmic reticulum stress
Dongsheng Wen, Yeke Yu, Siyi He, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2022
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
ZhiCheng Lai, MinKe He, XiaoYun Bu, et al.
Angewandte Chemie (International Ed. in English)
|
March 12, 2024
Control of Polarity in Kagome-NiAs Bismuthides
Quinn D Gibson, Dongsheng Wen, Hai Lin, et al.
Medcomm
|
June 10, 2026
Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial
Zhicheng Lai, Aojie Ge, Hanyue Ouyang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 14, 2025
Type 2 Diabetes-Associated Phenylacetylglutamine Induces Deleterious Inflammation Cycle in Myeloid Cells through β<sub>2</sub> Adrenergic Receptors and Impedes Wound Healing
Lu Huang, Xinran Ye, Chia-Kang Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC)
MinKe He, YeXing Huang, ZeFeng Du, et al.
Technology in Cancer Research & Treatment
|
December 19, 2022
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials
YeXing Huang, LiHong Zhang, MinKe He, et al.
Page
of 9